Evolent Health (EVH) | Stock Overview & Key Data
Evolent Health Performance Comparison
Stock Range
Today's Range
Low: $7.85
High: $8.23
on October 3, 2025
52 Week Range
Low: $7.06
High: $27.42
on May 23, 2025
on October 11, 2024
All-Time High: $39.78 on September 12, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.1B
EPS
-1.60
P/E Ratio (TTM)
-10.16
Forward P/E
5.76
P/B Ratio
1.06
PEG Ratio
-0.02
Div. Yield
N/A
ROE
-11.04%
Beta
0.660
Debt to Equity
75.85
Financial Highlights
Profitability
Gross Margin
22.59%
Operating Margin
0.64%
Profit Margin
-5.94%
Returns and Earnings
Return on Assets (TTM)
-0.21%
Return on Equity (TTM)
-11.04%
EBITDA
$92.0M
Net Income (TTM)
$-185.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$19.09
Quarterly Revenue Growth (YoY)
-31.30%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Evolent Health EVH | 1.06B Small-cap | -8.04% | -14.09% | -30.20% | -18.35% | -28.37% | -68.75% | -75.86% | -26.58% |
| Veeva Systems VEEV | 48.56B Large-cap | 2.07% | 9.35% | 4.22% | 33.77% | 40.70% | 44.76% | 78.66% | 0.73% |
| Ge Healthcare GEHC | 34.95B Large-cap | 5.66% | 5.78% | 0.64% | 6.33% | -2.32% | -16.25% | 34.93% | 34.93% |
| Teladoc Health TDOC | 1.59B Small-cap | 10.42% | 16.11% | 8.69% | 19.65% | -5.36% | -0.33% | -64.15% | -95.87% |
| 10x Genomics TXG | 1.59B Small-cap | 8.79% | -4.42% | -2.00% | 59.97% | -10.15% | -36.31% | -55.37% | -91.75% |
| GoodRx Holdings GDRX | 1.57B Small-cap | 12.13% | 5.59% | -3.82% | 5.59% | -0.66% | -36.11% | -8.85% | -91.55% |
Ownership & Short Interest
Insider Ownership
1.54%
Institutional Ownership
108.72%
Shares Short
23M
Short Ratio
7.22
Short % of Shares Outstanding
20.16%
Average 10-Day Volume
3M
Average 90-Day Volume
3M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EVH's 52-week high and low?
- In the last 52 weeks, Evolent Health reached a high of $27.42 (on October 11, 2024) and a low of $7.06 (on May 23, 2025).
- What is the market cap and P/E ratio for EVH?
- Curious about Evolent Health's size and valuation? Its market capitalization stands at 1.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is -10.16, and the forward P/E (looking ahead) is 5.76.
- Does EVH pay dividends? If so, what's the yield?
- As for dividends, Evolent Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Evolent Health's main competitors or similar companies to consider before investing?
When looking at Evolent Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV48.56B Healthcare Health Information Services 44.76% 78.66% Ge Healthcare
GEHC34.95B Healthcare Health Information Services -16.25% 34.93% Teladoc Health
TDOC1.59B Healthcare Health Information Services -0.33% -64.15% 10x Genomics
TXG1.59B Healthcare Health Information Services -36.31% -55.37% GoodRx Holdings
GDRX1.57B Healthcare Health Information Services -36.11% -8.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Evolent Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Evolent Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -11.04%, the Debt to Equity ratio from the most recent quarter is 75.85, and its Gross Profit Margin stands at 22.59%.
- What is the recent revenue and earnings growth for EVH?
- Looking at Evolent Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -31.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of EVH stock is held by insiders and institutions?
- Wondering who owns Evolent Health stock? Company insiders (like executives and directors) hold about 1.54% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.72%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.